1. Effects of Carotenoids on 3T3-L1 Preadipocyte Viability and Differentiation
    润草 高, 2015, BIPHY CrossRef
  2. The Suppressive Effect of a Marine Carotenoid, Fucoxanthin, on Mouse Ear Swelling through Regulation of Activities and mRNA Expression of Inflammation-associated Enzymes
    Yoshimasa Sugiura et al, 2016, FSTR CrossRef
  3. Screening of Diatom Strains and Characterization of Cyclotella cryptica as A Potential Fucoxanthin Producer
    Bingbing Guo et al, 2016, Marine Drugs CrossRef
  4. Marine Algae as a Potential Source for Anti-Obesity Agents
    Chu Wan-Loy et al, 2016, Marine Drugs CrossRef
  5. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells
    Hayato Maeda et al, 2015, Marine Drugs CrossRef
  6. Antitumor Effects of Laminaria Extract Fucoxanthin on Lung Cancer
    ChengHan Mei et al, 2017, Marine Drugs CrossRef
  7. Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry
    Yiping Zhang et al, 2015, Marine Drugs CrossRef
  8. In silico validation of microalgal metabolites against Diabetes mellitus
    Gurudeeban Selvaraj et al, 2017, Diabetes mellitus CrossRef
  9. Fucoxanthin and Its Metabolite Fucoxanthinol Do Not Induce Browning in Human Adipocytes
    Candida J. Rebello et al, 2017, J. Agric. Food Chem. CrossRef
  10. Antibacterial and Antioxidant Capacities and Attenuation of Lipid Accumulation in 3T3-L1 Adipocytes by Low-Molecular-Weight Fucoidans Prepared from Compressional-Puffing-Pretreated Sargassum Crassifolium
    , 2018, Marine Drugs CrossRef
  11. A Review of the Biological Activities of Microalgal Carotenoids and Their Potential Use in Healthcare and Cosmetic Industries
    Ramaraj Sathasivam et al, 2018, Marine Drugs CrossRef
  12. Fucoxanthin and Polyunsaturated Fatty Acids Co-Extraction by a Green Process
    Antoine Delbrut et al, 2018, Molecules CrossRef
  13. Overview on the Antihypertensive and Anti-Obesity Effects of Secondary Metabolites from Seaweeds
    Ana Seca et al, 2018, Marine Drugs CrossRef
  14. Degradation of Fucoxanthin to Elucidate the Relationship between the Fucoxanthin Molecular Structure and Its Antiproliferative Effect on Caco-2 Cells
    Shiro Komba et al, 2018, Marine Drugs CrossRef
  15. Novel Anti-Obesity Properties of Palmaria mollis in Zebrafish and Mouse Models
    Hiroko Nakayama et al, 2018, Nutrients CrossRef
  16. Effects of Quercetin Metabolites on Triglyceride Metabolism of 3T3-L1 Preadipocytes and Mature Adipocytes
    Itziar Eseberri et al, 2019, IJMS CrossRef
  17. Optimization and Formulation of Fucoxanthin-Loaded Microsphere (F-LM) Using Response Surface Methodology (RSM) and Analysis of Its Fucoxanthin Release Profile
    Irwandi Jaswir et al, 2019, Molecules CrossRef
  18. Seaweed Active Substances and Their Effects on Weight Loss and Lipid Reduction
    素琴 范, 2019, HJFNS CrossRef
  19. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice
    Fumiaki Beppu et al, 2009, J. Toxicol. Sci. CrossRef
  20. Single and 13-Week Oral Toxicity Study of Fucoxanthin Oil from Microalgae in Rats
    Kumiko IIO et al, 2011, J. Food Hyg. Soc. Jpn CrossRef
  21. Bacterial Reverse Mutation Test and Micronucleus Test of Fucoxanthin Oil from Microalgae
    Kumiko IIO et al, 2011, J. Food Hyg. Soc. Jpn CrossRef
  22. High Bioavailability and Diverse Biofunctions of Fucoxanthin in Brown algae
    Kazuki Kanazawa, 2012, Journal of The Japanese Society for Food Science and Technology CrossRef
  23. Anti-Obesity Effect of Carotenoids: Direct Impact on Adipose Tissue and Adipose Tissue-Driven Indirect Effects
    Lourdes Mounien et al, 2019, Nutrients CrossRef
  24. Fucoxanthin Extractions of Brown Seaweeds and Analysis of Their Lipid Fraction in Methanol
    Irwandi JASWIR et al, 2012, FSTR CrossRef
  25. Brown Macroalgae as Valuable Food Ingredients
    Nuno C. Afonso et al, 2019, Antioxidants CrossRef
  26. miRNAs and Novel Food Compounds Related to the Browning Process
    Silvia Lorente-Cebrián et al, 2019, IJMS CrossRef
  27. Fucus vesiculosus and Ascophyllum nodosum Ameliorate Liver Function by Reducing Diet-Induced Steatosis in Rats
    Daniela Gabbia et al, 2020, Marine Drugs CrossRef
  28. Fucoxanthinol from the Diatom Nitzschia Laevis Ameliorates Neuroinflammatory Responses in Lipopolysaccharide-Stimulated BV-2 Microglia
    Yuelian Li et al, 2020, Marine Drugs CrossRef
  29. Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes
    Maki Yoshikawa et al, 2020, Mol Biol Rep CrossRef
  30. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway
    Wenhui Jin et al, 2020, Marine Drugs CrossRef
  31. Scientific Approaches on Extraction, Purification and Stability for the Commercialization of Fucoxanthin Recovered from Brown Algae
    Catarina Lourenço-Lopes et al, 2020, Foods CrossRef
  32. Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases
    Daniela Gabbia et al, 2020, Molecules CrossRef
  33. Dietary Carotenoids in Managing Metabolic Syndrome and Role of PPARs in the Process
    Raghunandan Purohith et al, 2020, CNF CrossRef
  34. Unripe Rubus coreanus Miquel Extract Containing Ellagic Acid Promotes Lipolysis and Thermogenesis In Vitro and In Vivo
    Kyeong Jo Kim et al, 2020, Molecules CrossRef
  35. Effects of Ethanol Extracts from Grateloupia elliptica, a Red Seaweed, and Its Chlorophyll Derivative on 3T3-L1 Adipocytes: Suppression of Lipid Accumulation through Downregulation of Adipogenic Protein Expression
    Hyo-Geun Lee et al, 2021, Marine Drugs CrossRef
  36. Natural Extracts That Stimulate Adipocyte Browning and Their Underlying Mechanisms
    Min-Kyeong Lee et al, 2021, Antioxidants CrossRef
  37. Effects of Fucoxanthin on the Inhibition of Dexamethasone-Induced Skeletal Muscle Loss in Mice
    Maki Yoshikawa et al, 2021, Nutrients CrossRef
  38. Xanthophylls from the Sea: Algae as Source of Bioactive Carotenoids
    Antia G. Pereira et al, 2021, Marine Drugs CrossRef
  39. Atielogy, Prevention and Management of Obesity: A Nutritional Approach
    Oluwatoyin Oluwole, 2016, AOWMC CrossRef
  40. Comparing three different Phaeodactylum tricornutum strains for the production of chrysolaminarin in flat panel airlift photobioreactors
    Konstantin Frick et al, 2022, J Appl Phycol CrossRef
  41. Undaria pinnatifida (Wakame) Intake Ameliorates High-Fat Diet-Induced Glucose Intolerance via Promoting GLUT4 Expression and Membrane Translocation in Muscle
    Motoki Imai et al, 2023, Journal of Nutrition and Metabolism CrossRef
  42. Beta-glucan production of Phaeodactylum tricornutum, Monodopsis subterranea and Cylindrotheca fusiformis during nitrogen depletion
    Konstantin Frick et al, 2023, J Appl Phycol CrossRef
  43. Influence of light conditions on the production of chrysolaminarin using Phaeodactylum tricornutum in artificially illuminated photobioreactors
    Konstantin Frick et al, 2023, MicrobiologyOpen CrossRef
  44. Stability and Bioaccessibility of Fucoxanthin in Nanoemulsions Prepared from Pinolenic Acid-contained Structured Lipid
    Zhenghua Huang et al, 2017 CrossRef
  45. Exploring the Potential of Fucoxanthin Treatment to Alleviate Microplastic Pollution Effects on Maize Growth
    Farzad Rassaei, 2024, Soil and Sediment Contamination: An International Journal CrossRef
  46. Identification of the Secondary Metabolites of Sargassum Tenerrimum and their Molecular Docking Analysis against the Targets of Anxiety, Depression and Cognitive Disorder
    Raman Yadav et al, 2024, LDDD CrossRef
  47. Health impact of marine carotenoids
    Kazuo Miyashita et al, 2018 CrossRef